The increasing prevalence of neurological disorders, particularly Alzheimer’s disease and dementia, is significantly driving the growth of the global memantine industry. Growing awareness regarding cognitive health, rising geriatric population, and increasing demand for effective neurodegenerative disease treatments are contributing to market expansion worldwide. Pharmaceutical companies...
SPARK Website
عربي